Published on 04/12/2025

Evidence Rooms for AI: Index and Retrieval

In the pharmaceutical industry, the implementation of artificial intelligence (AI) and machine learning (ML) technology is evolving rapidly. The need for stringent validation approaches is paramount to ensure these technologies comply with regulatory expectations such as those outlined by the US FDA, the European Medicines Agency (EMA), and the Medicines and Healthcare products Regulatory Agency (MHRA). This comprehensive guide outlines the critical steps and considerations involved in the validation of AI and ML models, focusing on documentation, intended use risk assessment, data readiness and curation, bias and fairness testing, model verification and validation, and the establishment of robust documentation and audit trails.

Step 1: Understanding the Regulatory Framework

Before embarking on the validation process, it’s essential to understand the regulatory landscape concerning AI and ML in GxP (Good Practice) environments. Key regulations applicable include:

• 21 CFR Part 11: This regulation outlines the FDA’s criteria for electronic records and electronic signatures.
• Annex 11: The EU guideline that focuses on computerised systems and their validation within the pharmaceutical industry.
• GAMP 5: A guideline that provides a framework for the validation of automated systems throughout their lifecycle.

Familiarizing oneself with these regulations will help ensure compliance throughout the validation process and facilitate a smoother integration of AI/ML technology into existing systems.

Step 2: Defining Intended Use and Data Readiness

Establishing a clear understanding of the intended use of AI and ML models is vital. The intended use statement should cover the model’s objective, its operational environment, and the target population. This documentation should be aligned with scientific and regulatory requirements, ensuring all stakeholders understand the intended application.

In addition to defining intended use, assessing data readiness is crucial. This involves the following considerations:

• Data Collection: Ensure data is collected in a GxP-compliant manner, adhering to protocols set by regulatory bodies.
• Data Curation: All datasets must be accurately annotated and validated to meet integrity and quality standards.
• Data Completeness: It’s essential to confirm the dataset encompasses the full range of variability expected in real-world scenarios.

Proper documentation of the intended use and data readiness ensures a solid foundation for the validation process while mitigating the risk of regulatory non-compliance.

Step 3: Conducting Bias and Fairness Testing

With the ever-growing emphasis on ethical AI, bias and fairness testing is crucial. These tests help identify and mitigate biases that could lead to unfair treatment of certain populations. The following methodologies should be adopted:

• Training Data Analysis: Analyze training data to ensure it reflects diverse populations and circumstances.
• Model Performance Metrics: Utilize metrics that assess fairness and bias across different demographic groups.
• Continuous Monitoring: Engage in periodic review and drift analysis to monitor the model’s performance over time.

Documenting the process and outcomes of bias testing not only supports compliance with industry standards but also enhances the trustworthiness of the AI/ML models.

Step 4: Model Verification and Validation

The verification and validation (V&V) of AI and ML models involve ensuring that the models perform as intended under predefined conditions. This step is both crucial and multifaceted:

Model Verification

Model verification assures that the implementation of the model is correct. This process is divisioned into:

• Code Review: Review the model code to ensure functionalities align with specifications.
• Unit Testing: Conduct tests on individual components of the model to guarantee expected behavior.
• Integration Testing: Evaluate how different components work together to ensure the cohesive functioning of the model.

Model Validation

Model validation assesses whether the model achieves its intended use. This process includes:

• Performance Testing: Evaluate model performance using independent validation datasets; use metrics such as accuracy, precision, recall, and F1-score.
• Robustness Testing: Test the model under varied conditions to understand its performance stability.
• Usability Testing: Ensure the model’s interface is user-friendly and meets the technological requirements.

The documentation created during the V&V processes must be thorough and maintain compliance with industry standards to support regulatory reviews.

Step 5: Establishing Documentation and Audit Trails

In the context of AI and ML model validation, documentation serves as a critical element for compliance and operational integrity. It includes:

• Validation Plans and Reports: Create comprehensive validation plans outlining test scenarios, methodologies, and acceptance criteria.
• Audit Trails: Ensure electronic systems maintain traceability of modifications, decisions, and testing actions to comply with 21 CFR Part 11 and other regulatory standards.
• Change Control Documentation: Record all changes to algorithms, datasets, and software to maintain quality and compliance.

Having systematic documentation plays a dual role: it not only assures regulatory compliance but also acts as a reference for future audits and assessments.

Step 6: Implementing Explainability and Governance Measures

Explainable AI (XAI) relates to the interpretability of AI operations, which can emphasize decision-making transparency. This involves:

• Model Interpretation Techniques: Utilize techniques such as SHAP (SHapley Additive exPlanations) or LIME (Local Interpretable Model-Agnostic Explanations) to clarify model predictions.
• A Governance Framework: Formulate a governance structure for managing AI model performance, including data integrity and risk assessment.
• Security Measures: Incorporate cybersecurity protocols to protect sensitive data and models from unauthorized access and exploitation.

This governance approach not only guarantees ethical usage of AI models but also upholds compliance with legal standards and organizational policies.

Step 7: Drift Monitoring and Re-Validation

Once an AI/ML model is deployed, continuous monitoring is essential to ensure it remains effective and compliant. Model drift can occur due to changes in the underlying data or environment, necessitating re-validation.

• Drift Detection Techniques: Utilize statistical tests, such as Kolmogorov-Smirnov or Chi-Squared tests, to detect changes in data distributions.
• Periodic Review: Schedule regular reviews of model performance and compliance, adjusting validation strategies based on observed performance.
• Re-Validation Protocols: Establish protocols for re-validating models when significant drift is detected, ensuring documentation of the process and outcomes.

This approach ensures that the model continues to deliver accurate and reliable results throughout its lifecycle.

Conclusion

The validation of AI and ML models in GxP environments is a complex but necessary process to meet regulatory expectations and maintain product integrity. By carefully following the steps outlined in this guide—understanding the regulatory framework, defining intended use and data readiness, conducting bias and fairness testing, model verification and validation, establishing documentation and audit trails, implementing explainability and governance measures, and ensuring drift monitoring and re-validation—pharmaceutical companies can create trustworthy AI systems. Effective validation not only safeguards public health but also promotes innovation and growth in the pharmaceutical industry.